Mycobacteria and the new quinolones
- 1 January 1989
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (1) , 1-5
- https://doi.org/10.1128/aac.33.1.1
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of five new quinolones against cultivable MycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) againstMycobacterium fortuitum andMycobacterium chelonaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complexDiagnostic Microbiology and Infectious Disease, 1987
- In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987
- Effect of RO 23-6240 on sensitive and resistant intracellular mycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Fluorinated quinolonesInternational Journal of Clinical Pharmacy, 1986
- In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugsJournal of Antimicrobial Chemotherapy, 1985
- In vitro activity of ciprofloxacin against mycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- In-vitro activity of some quinoline derivatives against MycobacteriumfortuitumJournal of Antimicrobial Chemotherapy, 1985